Item request has been placed!

Item request cannot be made.

Processing Request

Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma

Item request has been placed!

Item request cannot be made.

Processing Request

Read More Add to Saved list

Author(s): Lauer, U.M.; Awada, A.; Postel-Vinay, S.; Shapiro, G.I.; Thieblemont, C.; Piha-Paul, S.A.; Paik, P.K.; Shepard, D.R.; Docampo, L.I.; Galot, R.; Rottey, S.; Sadrolhefazi, B.; Marzin, K.; Musa, H.; Schöffski, P.
Source:
ESMO Open ; volume 10, issue 5, page 104499 ; ISSN 2059-7029
Document Type:
article in journal/newspaper
Language:
English

Additional Information
- Contributors:
  Boehringer Ingelheim International GmbH; MSD Sharp and Dohme; Roche; Bristol-Myers Squibb
- Publication Information:
  Elsevier BV
- Publication Date:
  2025
- Collection:
  ScienceDirect (Elsevier - Open Access Articles via Crossref)
- Accession Number:
  10.1016/j.esmoop.2025.104499
- Online Access:
  https://doi.org/10.1016/j.esmoop.2025.104499
  https://api.elsevier.com/content/article/PII:S2059702925003680?httpAccept=text/xml
  https://api.elsevier.com/content/article/PII:S2059702925003680?httpAccept=text/plain
- Rights:
  https://www.elsevier.com/tdm/userlicense/1.0/ ; https://www.elsevier.com/legal/tdmrep-license ; http://creativecommons.org/licenses/by/4.0/
- Accession Number:
  edsbas.1DF1D601

Comments

No Comments.